TG Therapeutics | TGTX - Selling And Administration Expenses



TG Therapeutics reported $12.04M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Alaunos Therapeutics USD 845K 162K Dec/2024
Amgen USD 1.69B 4M Jun/2025
Ardelyx USD 83.99M 7.92M Jun/2025
Arrowhead Research USD 30.95M 3.06M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
Corcept Therapeutics USD 103.85M 13.19M Jun/2025
Dynavax Technologies USD 41.54M 64.79M Jun/2025
Gilead Sciences USD 1.36B 100M Jun/2025
J&J USD 5.89B 777M Jun/2025
Novartis USD 3.44B 384M Jun/2025
PTC Therapeutics USD 85.26M 76.66M Jun/2025
Regeneron Pharmaceuticals USD 634.2M 1.2M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
TG Therapeutics USD 12.04M 38.29M Jun/2025
Vertex Pharmaceuticals USD 424.6M 28.2M Jun/2025